These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 32141552)
1. TM4SF1 facilitates non-small cell lung cancer progression through regulating YAP-TEAD pathway. Fu XY; Zhou WB; Xu J Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1829-1840. PubMed ID: 32141552 [TBL] [Abstract][Full Text] [Related]
2. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis. Ye L; Pu C; Tang J; Wang Y; Wang C; Qiu Z; Xiang T; Zhang Y; Peng W Respir Res; 2019 May; 20(1):106. PubMed ID: 31142317 [TBL] [Abstract][Full Text] [Related]
3. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD. Yu M; Chen Y; Li X; Yang R; Zhang L; Huangfu L; Zheng N; Zhao X; Lv L; Hong Y; Liang H; Shan H Cell Death Dis; 2018 May; 9(5):464. PubMed ID: 29700328 [TBL] [Abstract][Full Text] [Related]
4. Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP/TEAD signaling. Liang Z; Wang Y; Shen Z; Teng X; Li X; Li C; Wu W; Zhou Z; Wang Z Tumour Biol; 2016 Aug; 37(8):10909-15. PubMed ID: 26886283 [TBL] [Abstract][Full Text] [Related]
5. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer. Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700 [TBL] [Abstract][Full Text] [Related]
6. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W; Zhang Y; Xia S Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353 [TBL] [Abstract][Full Text] [Related]
7. TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo. Cao J; Yang JC; Ramachandran V; Arumugam T; Deng DF; Li ZS; Xu LM; Logsdon CD Cell Physiol Biochem; 2016; 39(2):740-50. PubMed ID: 27459514 [TBL] [Abstract][Full Text] [Related]
8. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT. Xu D; Yang F; Wu K; Xu X; Zeng K; An Y; Xu F; Xun J; Lv X; Zhang X; Yang X; Xu L Cancer Biol Ther; 2020 Apr; 21(4):354-363. PubMed ID: 31906774 [No Abstract] [Full Text] [Related]
9. miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1. Ma YS; Yu F; Zhong XM; Lu GX; Cong XL; Xue SB; Xie WT; Hou LK; Pang LJ; Wu W; Zhang W; Cong LL; Liu T; Long HD; Sun R; Sun HY; Lv ZW; Wu CY; Fu D Mol Ther; 2018 Dec; 26(12):2751-2765. PubMed ID: 30301667 [TBL] [Abstract][Full Text] [Related]
10. Over-expression of TM4SF1 improves cell metastasis and growth by activating ERK1/2 signaling pathway in human prostate cancer. Chen J; Wang F; Xu H; Chen D; Liu W; Wang J J BUON; 2019; 24(6):2531-2538. PubMed ID: 31983129 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p. Jing H; Xia H; Qian M; Lv X Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121 [TBL] [Abstract][Full Text] [Related]
13. 4,5-Dimethoxycanthin-6-one Inhibits Glioblastoma Stem Cell and Tumor Growth by Inhibiting TSPAN1 Interaction with TM4SF1. Li W; Yang LJ; Xiong YY; Li ZS; Li X; Wen Y Neurochem Res; 2024 Oct; 49(10):2897-2909. PubMed ID: 39060768 [TBL] [Abstract][Full Text] [Related]
14. m Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857 [TBL] [Abstract][Full Text] [Related]
15. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway. Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723 [TBL] [Abstract][Full Text] [Related]
16. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer. Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway. Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256 [TBL] [Abstract][Full Text] [Related]
18. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway. Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569 [TBL] [Abstract][Full Text] [Related]
19. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. Xu L; Li Q; Xu D; Wang Q; An Y; Du Q; Zhang J; Zhu Y; Miao Y Int J Oncol; 2014 Feb; 44(2):459-66. PubMed ID: 24285464 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer. Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]